Duopharma’s capacity set to expand

With the commissioning of the K3 facility, Duopharma’s manufacturing capacity has increased by some 50%.

KUALA LUMPUR: Duopharma Biotech Bhd expects the additional capacity from its new K3 facility in Klang to be fully utilised over the next three years, analysts say.

With the commissioning of the K3 facility, Duopharma’s manufacturing capacity has increased by some 50%.